Daniel Barber
2019
In 2019, Daniel Barber earned a total compensation of $1.2M as Chief Operating Officer at Aquestive Therapeutics, a 43% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $227,780 |
|---|---|
| Option Awards | $555,257 |
| Salary | $388,846 |
| Other | $23,345 |
| Total | $1,195,228 |
Barber received $555.3K in option awards, accounting for 46% of the total pay in 2019.
Barber also received $227.8K in non-equity incentive plan, $388.8K in salary and $23.3K in other compensation.
Rankings
In 2019, Daniel Barber's compensation ranked 8,454th out of 13,971 executives tracked by ExecPay. In other words, Barber earned more than 39.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,454 out of 13,971 | 40th |
Division Manufacturing | 3,348 out of 5,701 | 41st |
Major group Chemicals And Allied Products | 1,269 out of 2,200 | 42nd |
Industry group Drugs | 1,079 out of 1,886 | 43rd |
Industry Pharmaceutical Preparations | 800 out of 1,398 | 43rd |
Source: SEC filing on April 29, 2020.
Barber's colleagues
We found two more compensation records of executives who worked with Daniel Barber at Aquestive Therapeutics in 2019.
News
Aquestive Therapeutics CEO Daniel Barber's 2023 pay jumps 88% to $2.5M
April 26, 2024
Aquestive Therapeutics CEO Keith Kendall's 2021 pay jumps 59% to $2M
April 29, 2022
Aquestive Therapeutics CFO John Maxwell's 2020 pay jumps 24% to $1.3M
May 5, 2021
Aquestive Therapeutics CEO Keith Kendall's 2019 pay falls 67% to $2.6M
April 29, 2020